vVARDIS Holding AG: vVARDIS Announces Pricing of Initial Public Offering

vVARDIS Holding AG, a Swiss dental med-tech company, priced its IPO at $18 per share for 9,722,223 Class A shares, with an over-allotment option. Trading is expected to begin on the NYSE under 'VVVV' on November 13, 2026. Goldman Sachs and J.P. Morgan are joint bookrunners. The offering is expected to close on November 16, 2026, subject to conditions.

Original reporting

finanznachrichten.de

Published Nov 13, 2026, 6:00 AM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Nov 13, 2026, 6:05 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefIPO

Primary signal

$VVVV

Bullish

high confidence

Mentioned

$VVVV

Relevance

8/10

AlphAI data visualization · based on finanznachrichten.de

Decision brief

The 30-second read

$VVVVBullishHigh

Why it matters

The IPO pricing sets the market's initial valuation and may influence investor appetite for similar niche healthcare listings.

Market read

First‑report IPO pricing creates immediate trading opportunity and adds a new listed entity in the healthcare sector.

What to watch

Potential regulatory hurdles for dental devices and competition from established oral‑care giants could limit upside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

vVARDIS is a Swiss dental med‑tech firm launching its first public offering, with Goldman Sachs and J.P. Morgan as bookrunners.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$VVVVBullishHigh confidence

Context

vVARDIS announced pricing of its IPO at $18 per share, targeting a $175M raise and NYSE debut on Nov 13.

Expected impact

potential upward pressure as the market prices in the new supply and growth story

Evidence & confidence

First‑report of pricing, sizable raise, and NYSE listing create immediate trading interest.

Market effects

Sector

Adds a new public player in the dental med‑tech space, may spur valuation re‑ratings for peers.

Regional

Positive for Swiss healthcare listings and may boost investor interest in Swiss biotech/med‑tech IPOs.

Global

Modest; primarily relevant to US and European investors tracking healthcare IPO pipelines.

Counterpoint

What could challenge this read

If demand for med‑tech IPOs wanes, the new issue could face pricing pressure and under‑performance.

Key entities

company
vVARDIS Holding AG
Swiss dental med‑tech company issuing the IPO.
financial_institution
Goldman Sachs Co. LLC
Joint bookrunner for the offering.
financial_institution
J.P. Morgan
Joint bookrunner for the offering.

Read at source ← All news

$VVVVHighAI 8/10

New York Stock Exchange: vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update

vVardis (NYSE: VVVV) raised $175 million in its IPO, pricing 9.72 million shares at $18 each. The dental health firm offers a peptide-based treatment for early cavities. VAST Data secured $10 billion in commitments for its AI operating system. Kraft Heinz (NYSE: KHC) discussed growth plans after a 0.9% share price increase. Both vVardis and Revvity (NYSE: RVTY) celebrated milestones on the NYSE.

finanznachrichten.deNov 13

$VVVVHighAI 8/10

vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update

vVardis (VVVV) raised $175M in its IPO, pricing 9.72M shares at $18 each. The dental health firm will list on the NYSE. VAST Data secured $10B in commitments for its AI OS. Kraft Heinz (KHC) shares rose 0.9% on Thursday. Both vVardis and VAST Data's leaders will join NYSE Live.

prnewswire.comNov 13

$VVVVMedAI 8/10

VVARDIS Holding Prices 9.72 Mln Class A Ordinary Shares IPO At $18/shr

VVARDIS Holding AG, a Swiss healthcare firm, priced its IPO of 9.72 million Class A shares at $18 each, with a 30-day over-allotment option for 1.46 million more. Trading is set to begin on the NYSE under 'VVVV' on November 13, 2026. Goldman Sachs and J.P. Morgan are joint bookrunners.

rttnews.comNov 13

$VVVVHigh

vVARDIS Holding AG Prices IPO at $18.00 per Share

vVARDIS Holding AG priced 9,722,223 Class A shares at $18.00 each for its IPO. Trading is set to begin on the NYSE on November 13, 2026, under the ticker VVVV, with the offering expected to close around November 16, pending customary conditions.

tradingview.comNov 13

$GOOGHighAI 8/10

Forget SpaceX: This Potential Blockbuster IPO Has Attracted $26 Billion From AI Giants

Anthropic, an AI company, is preparing for an IPO with a potential market cap of $1.4 trillion, down from earlier estimates. It has secured $26 billion in investments from major AI players like Alphabet, Nvidia, and Microsoft. The company reported $33.2 billion in revenue for the nine months ended Sept. 30, but remains unprofitable. The IPO is expected to take place next week.

finance.yahoo.comNov 14

$ANTHighAI 8/10

Asian Markets Surge as Investors Eye Anthropic's Historic Nasdaq Debut Next Week

Asian markets surged, with Taipei, Seoul, and Tokyo gaining 1.3% to 3%, ahead of Anthropic's Nasdaq IPO. Semiconductor stocks like SK Hynix, Samsung, and TSMC led the rally. Anthropic's IPO, priced at $70-$78 per share, could raise $64.35B, valuing the company at up to $1.4T. The company reported rapid revenue growth and its first operating profit. Nvidia's CEO resignation had minimal impact on broader market sentiment.

latintimes.comNov 14